Hikma Injectables USA Inc. is recalling one lot of Phenylephrine in 0.9% Sodium Chloride Injection (100mcg/mL, 5mL syringe) because some syringes were mistakenly labeled with the wrong medication. Specifically, syringes containing ephedrine were mislabeled as phenylephrine. If a patient is accidentally given ephedrine when phenylephrine is intended, it can cause severe health complications due to incorrect blood pressure and heart rate management. Healthcare facilities should immediately identify and stop using the affected syringes.
Administering the wrong medication during a medical procedure can lead to unintended cardiovascular effects, including dangerous changes in blood pressure or heart rate. Because these drugs are used in critical care and surgical settings, a labeling mix-up poses a high risk of patient harm or ineffective treatment.
Manufacturer initiated recall via letter.
Labeling mix-up where ephedrine syringes were mislabeled as phenylephrine.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.